PT74949B - Process for the preparation of lysin salts of acid 5-(p-chlorobenzoyl)-1,4-dymetil-pyrrol-2-acetic with analgesic activity - Google Patents

Process for the preparation of lysin salts of acid 5-(p-chlorobenzoyl)-1,4-dymetil-pyrrol-2-acetic with analgesic activity

Info

Publication number
PT74949B
PT74949B PT74949A PT7494982A PT74949B PT 74949 B PT74949 B PT 74949B PT 74949 A PT74949 A PT 74949A PT 7494982 A PT7494982 A PT 7494982A PT 74949 B PT74949 B PT 74949B
Authority
PT
Portugal
Prior art keywords
dymetil
lysin
chlorobenzoyl
pyrrol
acetic
Prior art date
Application number
PT74949A
Other languages
Portuguese (pt)
Other versions
PT74949A (en
Original Assignee
Poli Ind Chimica Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Poli Ind Chimica Spa filed Critical Poli Ind Chimica Spa
Publication of PT74949A publication Critical patent/PT74949A/en
Publication of PT74949B publication Critical patent/PT74949B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/337—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01S—RADIO DIRECTION-FINDING; RADIO NAVIGATION; DETERMINING DISTANCE OR VELOCITY BY USE OF RADIO WAVES; LOCATING OR PRESENCE-DETECTING BY USE OF THE REFLECTION OR RERADIATION OF RADIO WAVES; ANALOGOUS ARRANGEMENTS USING OTHER WAVES
    • G01S3/00—Direction-finders for determining the direction from which infrasonic, sonic, ultrasonic, or electromagnetic waves, or particle emission, not having a directional significance, are being received
    • G01S3/78—Direction-finders for determining the direction from which infrasonic, sonic, ultrasonic, or electromagnetic waves, or particle emission, not having a directional significance, are being received using electromagnetic waves other than radio waves
    • G01S3/782—Systems for determining direction or deviation from predetermined direction
    • G01S3/783—Systems for determining direction or deviation from predetermined direction using amplitude comparison of signals derived from static detectors or detector systems
PT74949A 1981-05-26 1982-05-24 Process for the preparation of lysin salts of acid 5-(p-chlorobenzoyl)-1,4-dymetil-pyrrol-2-acetic with analgesic activity PT74949B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT21949/81A IT1137229B (en) 1981-05-26 1981-05-26 ANALGESIC ACTIVITY SOLUBLE COMPOUND

Publications (2)

Publication Number Publication Date
PT74949A PT74949A (en) 1982-06-01
PT74949B true PT74949B (en) 1983-12-23

Family

ID=11189271

Family Applications (1)

Application Number Title Priority Date Filing Date
PT74949A PT74949B (en) 1981-05-26 1982-05-24 Process for the preparation of lysin salts of acid 5-(p-chlorobenzoyl)-1,4-dymetil-pyrrol-2-acetic with analgesic activity

Country Status (10)

Country Link
JP (1) JPS57200359A (en)
KR (1) KR860000292B1 (en)
BE (1) BE893039A (en)
CA (1) CA1171421A (en)
DE (1) DE3219605A1 (en)
ES (1) ES512510A0 (en)
FR (1) FR2506766A1 (en)
GB (1) GB2098989B (en)
IT (1) IT1137229B (en)
PT (1) PT74949B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1210673B (en) * 1982-02-26 1989-09-20 Medosan Ind Biochimi PYROLACETIC STARCHES ANTI-INFLAMMATORY ACTIVITY
IT1197688B (en) * 1983-07-29 1988-12-06 Medosan Ind Biochimi ANTI-FLOGISTIC, ANALGESIC, ANTIPIRETIC AND ANTI-AGGREGATING PLASTER ACTIVITY OF 1-METHYL-5-METHYLBENZOYLPYRROL-2-ACETAMIDE ACETANILIDI
DE3328401A1 (en) * 1983-08-05 1985-02-21 Merckle GmbH, 7902 Blaubeuren INJECTABLE SOLUTION FOR TREATING INFLAMMATION
US4988822A (en) * 1986-05-29 1991-01-29 Syntex (U.S.A.) Inc. Intermediates for preparing 5-aroyl-1,2-dihydro-3H-pyrrolo(1,2-A)pyrrole-1,1-dicarboxylates
US4873340A (en) * 1986-05-29 1989-10-10 Syntex (U.S.A.) Inc. Process for preparing 5-aroyl-1,2-dihydro-3H-pyrrolo[1,2-A]pyrrole-1,1-dicarboxylates
GB8819569D0 (en) * 1988-08-17 1988-09-21 Dow Corning Ltd Emulsions for treating fibrous materials
KR100898501B1 (en) * 2007-09-03 2009-05-21 윤주평 Solar photovoltatics tracking system that use CDS element
KR101091936B1 (en) * 2009-08-31 2011-12-08 에스디엔 주식회사 Apparatus for detecting sunlight incident angle using pyranometer sensor

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4213905A (en) * 1979-06-25 1980-07-22 Mcneilab, Inc. Preparation of 5-aroyl-1-loweralkylpyrrole-2-acetic acid salts

Also Published As

Publication number Publication date
GB2098989B (en) 1984-10-10
FR2506766A1 (en) 1982-12-03
ES8302653A1 (en) 1983-02-01
PT74949A (en) 1982-06-01
IT1137229B (en) 1986-09-03
ES512510A0 (en) 1983-02-01
KR830010067A (en) 1983-12-26
JPS57200359A (en) 1982-12-08
IT8121949A0 (en) 1981-05-26
DE3219605A1 (en) 1982-12-23
BE893039A (en) 1982-08-16
CA1171421A (en) 1984-07-24
GB2098989A (en) 1982-12-01
KR860000292B1 (en) 1986-03-26

Similar Documents

Publication Publication Date Title
NO156609C (en) ANALOGY PROCEDURE FOR PREPARING DERIVATIVES OF OCTAHYDRO-1H-INDOL-2-CARBOXYL ACIDS WITH ANTIHYPERTENSIVE ACTIVITY.
NO853293L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE HETEROCYCLIC DERIVATIVES.
NO860332L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE ALFA- (2-OXO-2,4,5,6,7,7A-HEXSAHYDRO-TIENO (3,2-C) -5-PYRIDYL) -PHENYL-ACETIC ACID DERIVATIVES.
EP0197474A3 (en) Process for preparing optically active indoline-2-carboxylic acid
NO862408D0 (en) PROCEDURE FOR THE PREPARATION OF THIAZOLIDINE-4 (S) CARBOXYLIC ACID DERIVATIVES.
NO814424L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVITIES 5,5`-AZOBIS-SALICYLIC ACID COMPOUNDS.
NO820581L (en) MACHINE FOR THE PREPARATION OF CARBON ACID DRINK
NO822704L (en) PROCEDURE FOR THE PREPARATION OF INSULIN DERIVATIVES.
PT74949B (en) Process for the preparation of lysin salts of acid 5-(p-chlorobenzoyl)-1,4-dymetil-pyrrol-2-acetic with analgesic activity
IL72597A (en) 2-(3-carboxy-(hetero)aryl)-imidazolidinones and imidazolidinethiones,process for the preparation thereof,and use of said compounds as herbicidal agents
ZA828085B (en) Derivatives of cis,endo-2-azabicyclo-(3.3.0)-octane-3-carboxylic acid,a process for their preparation,agents containing these compounds and their use
PL239642A1 (en) Process for preparing derivatives of penicillanic acid 1,1-dioxide
IT1122324B (en) AMOIDS OF 1,2,3-TRIAZOL CARBOXYLIC ACID, PROCEDURE FOR PREPARING THESE COMPOUNDS AS WELL AS BIOCIDAL MEDIA CONTAINING THEM
PT81439A (en) Process for preparing imidazolium salts useful as hypoglycemic agents
ZA823487B (en) Compounds with antiinflammatory and analgesic activity, process for the preparation thereof and pharmaceutical compositions therefrom
HUT34458A (en) Process for preparing substituted tetrazole derivatives with pharmaceutical activity
NO873727D0 (en) PROCEDURE FOR THE PREPARATION OF BENZOXAZONINE COMPOUNDS WITH THERAPEUTIC ACTIVITY.
GR880100136A (en) Process for the preparation of 3-(2-haldgenethylo)-1,4-sulphurus acid and 2-(2-halogenethylo)-1,4-disulphurus acid
FI93725B (en) Process for the preparation of optically active, dextrorotatory oxo-isoindolinyl derivatives
PT76077B (en) Process for preparing 6-aminoalkylpenicillanic acid 1,1-dioxides and derivatives as beta-lactamase inhibitors
NO164599C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 7-D-MANDELAMIDO-3- (1-SULPHOMETHYL-TETRAZOL-5-YL) -TIOMETHYL-3-CEFEM-4-CARBOXYLIC ACID MONONATRUM SALT.
JPS5564585A (en) Heterocyclic compound for drug
ES512966A0 (en) "PROCEDURE FOR PREPARING SULFIMIDE DERIVATIVES OF N-CARBAMOILBENZOIC ACID".
ZA817820B (en) New 5-(n-alkyl-n-acyl-amino)-thiophen-2-carboxylic acid derivatives,process for producing the same and pharmaceutical compounds containing the same
DK107385A (en) OMEGA ((2-HYDROXYPHENYL) -METHYLENAMINO) -PHENYLALCANCARBOXYLIC ACID DERIVATIVES, PROCEDURES FOR PREPARING THEREOF, AND THE MEDICINAL PRODUCT CONTAINING THE COMPOUNDS